These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3940624)

  • 1. Serum immunosuppressive substance in patients with gynecologic malignancies and in pregnant women.
    Yamashita K; Hayashi H; Mure K; Ishikawa M; Shimizu T
    Cancer; 1986 Jan; 57(1):69-74. PubMed ID: 3940624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Variations in the level of immunosuppressive acidic protein in patients with gynecologic tumors and pregnant women].
    Sawada M; Okudaira Y; Matsui Y; Miyoshi Y; Takayama K; Shimizu Y; Miura S
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1823-30. PubMed ID: 6882005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive acidic protein in patients with gynecologic cancer.
    Sawada M; Okudaira Y; Matsui Y; Shimizu Y
    Cancer; 1984 Aug; 54(4):652-6. PubMed ID: 6744202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of serum sialosyl-Tn antigen levels in comparison with CA 125 levels in gynecologic cancers.
    Ryuko K; Iwanari O; Nakayama S; Iida K; Kitao M
    Cancer; 1992 May; 69(9):2368-78. PubMed ID: 1562985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of serum ferritin in female genital neoplasms].
    Dong MY
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):21-3, 61. PubMed ID: 1848498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppressive acidic protein in patients with gynecologic cancer].
    Sawada M; Matsui Y; Okudaira Y; Shimizu Y; Takayama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):605-11. PubMed ID: 6408203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of N-acetylneuraminic acid (NANA) in the serum of patients with gynecologic cancers].
    Schrempel A; Kürschner M
    Zentralbl Gynakol; 1985; 107(3):175-8. PubMed ID: 3984572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical value of tissue polypeptide antigen in patients with gynecologic tumors.
    Inoue M; Inoue Y; Hiramatsu K; Ueda G
    Cancer; 1985 Jun; 55(11):2618-23. PubMed ID: 3995474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum ferritin and trophoblastic globulin in genital tumors in women].
    Griaznova IM; Borisenko SA; Markarov OV; Fomina MB; Prokopenko PG; Tatarinov IuS
    Vopr Onkol; 1990; 36(2):181-7. PubMed ID: 2180208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum vitamins A and E and carotene in patients with gynecologic cancer.
    Heinonen PK; Kuoppala T; Koskinen T; Punnonen R
    Arch Gynecol Obstet; 1987; 241(3):151-6. PubMed ID: 3435184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyamine levels in gynecologic malignancies.
    Hayase R; Eguchi K; Sekiba K
    Acta Med Okayama; 1985 Feb; 39(1):35-45. PubMed ID: 3984779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early hemostatic disorders in patients with gynecologic tumors.
    Di Roberto P; Benedetti Panici P; Scambia G; Laghi F; Margariti PA; Mancuso S; Bompiani A
    Eur J Gynaecol Oncol; 1986; 7(2):109-12. PubMed ID: 2941303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of circulating tumor necrosis factor-alpha in patients with gynecological malignancies.
    De Jaco P; Asselain B; Orlandi C; Fridman WH; Teillaud JL
    Int J Cancer; 1991 May; 48(3):375-8. PubMed ID: 2040531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of serum copper/zinc ratio in gynecological tumors.
    Brandes JM; Lightman A; Drugan A; Zinder O; Cohen A; Itskovtiz J
    Acta Obstet Gynecol Scand; 1983; 62(3):225-9. PubMed ID: 6624394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratin fragment 21-1 in gynecologic malignancy: comparison with cancer antigen 125 and squamous cell carcinoma-related antigen.
    Inaba N; Negishi Y; Fukasawa I; Okajima Y; Ota Y; Tanaka K; Matsui H; Iwasaki H; Sudo H; Tanaka N
    Tumour Biol; 1995; 16(6):345-52. PubMed ID: 7569681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavior of the serum concentration of pregnancy associated alpha 2 glycoprotein (alpha 2-PAG) in gynecologic carcinomas (author's transl)].
    Tatra G
    Strahlentherapie; 1981 Jul; 157(7):464-7. PubMed ID: 7268817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of CA 125 and CA 19-9 tumor-associated antigens in sera of patients with gynecologic, trophoblastic, and colorectal tumors.
    Göcze PM; Szabó DG; Than GN; Csaba IF; Krommer KF
    Gynecol Obstet Invest; 1988; 25(4):268-72. PubMed ID: 2841208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers.
    Xu Y; Shen Z; Wiper DW; Wu M; Morton RE; Elson P; Kennedy AW; Belinson J; Markman M; Casey G
    JAMA; 1998 Aug; 280(8):719-23. PubMed ID: 9728644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple biochemical markers in patients with gynecologic malignancies.
    Donaldson ES; van Nagell JR; Pursell S; Gay EC; Meeker WR; Kashmiri R; van deVoorde J
    Cancer; 1980 Mar; 45(5):948-53. PubMed ID: 6167342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of sialyl Tn antigen in patients with gynecologic tumors.
    Inoue M; Ogawa H; Nakanishi K; Tanizawa O; Karino K; Endo J
    Obstet Gynecol; 1990 Jun; 75(6):1032-6. PubMed ID: 2342728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.